• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Delaware, known as the First State, has been progressive in its approach towards medical marijuana, legalizing it in 2011 under the Delaware Medical Marijuana Act (DMMA). The Act allows patients with certain debilitating conditions to use medical marijuana as a form of treatment. This report provides an overview of the policies, regulations, and the current state of medical marijuana in Delaware.

The DMMA, signed into law by Governor Jack Markell, allows patients with a physician's certification to possess up to six ounces of marijuana. If you liked this report and you would like to acquire additional details with regards to Cannabis Docs of Delaware kindly go to our own web-site. The law also permits the operation of compassion centers, which are facilities authorized to produce, process, and dispense medical marijuana. As of now, there are four operational compassion centers in Delaware, located in Wilmington, Lewes, Smyrna, and Newark.

To qualify for medical marijuana use in Delaware, patients must be diagnosed with one or more of the following conditions: cancer, HIV/AIDS, decompensated cirrhosis, ALS, Alzheimer's disease, post-traumatic stress disorder, or conditions causing seizures, severe nausea, severe pain, or muscle spasms. The list of qualifying conditions has expanded over the years, with the most recent addition being pediatric autism with self-injurious or aggressive behavior.

Patients seeking to use medical marijuana must apply for a Medical Marijuana Program (MMP) card through the Delaware Division of Public Health. The application process involves a physician's certification of the qualifying condition, a background check, and a registration fee. Once approved, the patient receives an MMP card, which must be presented at a compassion center to purchase medical marijuana.

The state of Delaware strictly regulates the production, processing, and dispensing of medical marijuana. Compassion centers must comply with a range of requirements, including security measures, record-keeping, and product testing. The state also imposes limits on the amount of marijuana that can be dispensed to a patient within a 14-day period.

Despite the progressive laws, the medical marijuana program in Delaware has faced challenges. The number of registered patients has grown significantly since the program's inception, leading to supply shortages. Additionally, the high cost of medical marijuana has been a barrier for many patients, as insurance companies do not cover it.

In response to these challenges, the state has taken steps to improve the program. In 2016, the DMMA was amended to allow each county to have more than one compassion center, increasing the availability of medical marijuana. The state has also been exploring ways to reduce the cost of medical marijuana, including the possibility of allowing home cultivation.

In conclusion, Delaware's medical marijuana program, while not without its challenges, has made significant strides since its inception. The state continues to refine its policies and regulations to ensure that patients with debilitating conditions have access to this form of treatment. As medical marijuana becomes more accepted nationwide, Delaware's program serves as an example of a balanced approach that prioritizes patient needs while maintaining strict regulatory controls.